Hinge Health (HNGE) Research & Development (2024 - 2026)

Hinge Health (HNGE) has 3 years of Research & Development data on file, last reported at $30.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 35.06% year-over-year to $30.3 million; the trailing twelve-month figure through Mar 2026 stood at $351.8 million (up 444.07% YoY), and the FY2025 full-year result was $368.1 million, up 265.07% from the prior year.
• Research & Development eased to $30.3 million in Q1 2026, from $110.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $147.2 million in Q2 2025 to a low of -$30.8 million in Q4 2024.
• A 3-year average of $52.1 million and a median of $38.5 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 490.8% in 2025 and plunged 35.06% in 2026, its largest moves.
• Tracing HNGE's Research & Development over 3 years: stood at -$30.8 million in 2024, then surged by 459.7% to $110.7 million in 2025, then plunged by 72.59% to $30.3 million in 2026.
• Business Quant data shows HNGE's Research & Development at $30.3 million in Q1 2026, $110.7 million in Q4 2025, and $63.5 million in Q3 2025.